Associate Editor

Thomas Martin, MD

Associate Editor

Dr. Martin is Clinical Research Director of Hematologic Malignancies at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center.

Articles by Thomas Martin, MD

Thomas Martin, MDMyeloma | February 7, 2023
Thomas G. Martin, MD, and Saad Z. Usmani, MD, MBA, FACP, debate CAR-T vs bispecific antibodies for R/R MM.
Read More
Elias Jabbour, MDViewpoints | January 3, 2023
As 2022 came to a close, the Blood Cancers Today Editorial Board shared their highlights from the year.
Chadi Nabhan, MD, MBA, FACPVideo Insights | December 14, 2022
Thomas Martin, MD, discusses advances in frontline treatments for multiple myeloma, the need for novel agents, and more.
Thomas Martin, MDMyeloma | October 13, 2022
We are entering the great era of immunotherapy in multiple myeloma, as we’ve had significant...